trending Market Intelligence /marketintelligence/en/news-insights/trending/xYjZLp60G8I-Ypzu1tBZuA2 content esgSubNav
In This List

CEL-SCI appoints board member

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


CEL-SCI appoints board member

CEL-SCI Corp. appointed Robert Watson to the company's board of directors.

Watson is the president of the preparedness technology division at Intermedix Technologies.

He was earlier president and chief growth officer of NantHealth, Inc. and CEO of Streamline Health Solutions, Inc.